ATE246936T1 - Kombiniertes menningitis vakzine - Google Patents

Kombiniertes menningitis vakzine

Info

Publication number
ATE246936T1
ATE246936T1 AT95935550T AT95935550T ATE246936T1 AT E246936 T1 ATE246936 T1 AT E246936T1 AT 95935550 T AT95935550 T AT 95935550T AT 95935550 T AT95935550 T AT 95935550T AT E246936 T1 ATE246936 T1 AT E246936T1
Authority
AT
Austria
Prior art keywords
vaccine
combined
menningitis
combined vaccine
bacterial meningitis
Prior art date
Application number
AT95935550T
Other languages
German (de)
English (en)
Inventor
Costante Ceccarini
Paolo Costantino
Ascenzi Sandro D
Francesco Norelli
Aldo Giannozzi
Original Assignee
Chiron Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10763774&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE246936(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiron Spa filed Critical Chiron Spa
Application granted granted Critical
Publication of ATE246936T1 publication Critical patent/ATE246936T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/831—Drug, bio-affecting and body treating compositions involving capsular polysaccharide of bacterium, e.g. polyribosyl ribitol phosphate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
AT95935550T 1994-11-02 1995-11-02 Kombiniertes menningitis vakzine ATE246936T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9422096A GB9422096D0 (en) 1994-11-02 1994-11-02 Combined meningitis vaccine
PCT/IB1995/001006 WO1996014086A1 (en) 1994-11-02 1995-11-02 Combined meningitis vaccine

Publications (1)

Publication Number Publication Date
ATE246936T1 true ATE246936T1 (de) 2003-08-15

Family

ID=10763774

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95935550T ATE246936T1 (de) 1994-11-02 1995-11-02 Kombiniertes menningitis vakzine

Country Status (12)

Country Link
US (1) US6251401B1 (OSRAM)
EP (3) EP2204185A1 (OSRAM)
JP (3) JP3989951B2 (OSRAM)
AT (1) ATE246936T1 (OSRAM)
CA (2) CA2689871A1 (OSRAM)
CY (1) CY2423B1 (OSRAM)
DE (1) DE69531501T3 (OSRAM)
DK (1) DK0789587T4 (OSRAM)
ES (1) ES2204967T5 (OSRAM)
GB (1) GB9422096D0 (OSRAM)
PT (1) PT789587E (OSRAM)
WO (1) WO1996014086A1 (OSRAM)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9422096D0 (en) * 1994-11-02 1994-12-21 Biocine Spa Combined meningitis vaccine
US6048527A (en) * 1996-08-27 2000-04-11 Chiron Corporation Antibodies that define unique Meningococcal B epitopes and vaccine compositions
ATE208629T1 (de) 1996-08-27 2001-11-15 Chiron Corp Neisseria meningitidis serogruppe b glykokonjugate und verfahren zu deren verwendung
JP2002508748A (ja) * 1997-05-01 2002-03-19 カイロン コーポレイション アジュバントとしてのウイルス様粒子の使用
EP0983342B1 (en) * 1997-05-28 2007-09-05 Novartis Vaccines and Diagnostics S.r.l. Culture medium with soy bean extract as aminoacid source and no protein complexes of animal origin
US20040087020A1 (en) 1997-05-28 2004-05-06 Chiron S.P.A. Culture medium with yeast or soy bean extract as amino acid source and no protein complexes of animal origin
US20070259007A1 (en) * 1999-10-19 2007-11-08 Kruzel Marian L Lactoferrin: an adjuvant for vaccines
DK1233784T3 (da) * 1999-12-02 2008-09-01 Novartis Vaccines & Diagnostic Præparater og fremgangsmåder til stabilisering af biologiske molekyler efter lyofilisering
GB0108364D0 (en) * 2001-04-03 2001-05-23 Glaxosmithkline Biolog Sa Vaccine composition
KR100898845B1 (ko) * 2000-06-29 2009-05-21 글락소스미스클라인 바이오로지칼즈 에스.에이. 다가 백신 조성물
US7534444B2 (en) 2001-04-17 2009-05-19 Novattis Vaccines And Diagnostics, Inc. Molecular mimetics of meningococcal B epitopes which elicit functionally active antibodies
GB0115176D0 (en) 2001-06-20 2001-08-15 Chiron Spa Capular polysaccharide solubilisation and combination vaccines
AR045702A1 (es) 2001-10-03 2005-11-09 Chiron Corp Composiciones de adyuvantes.
MX339524B (es) 2001-10-11 2016-05-30 Wyeth Corp Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
GB0302218D0 (en) * 2003-01-30 2003-03-05 Chiron Sri Vaccine formulation & Mucosal delivery
MXPA04011249A (es) * 2002-05-14 2005-06-06 Chiron Srl Vacunas mucosales con adyuvante de quitosano y antigenos meningococicos.
US20030124139A1 (en) * 2002-11-20 2003-07-03 Irina Esikova Compositions and methods for stabilizing biological molecules upon lyophilization
JP4827726B2 (ja) 2003-01-30 2011-11-30 ノバルティス ヴァクシンズ アンド ダイアグノスティクス エスアールエル 複数の髄膜炎菌血清群に対する注射可能ワクチン
US7731967B2 (en) 2003-04-30 2010-06-08 Novartis Vaccines And Diagnostics, Inc. Compositions for inducing immune responses
ES2397923T3 (es) 2003-10-02 2013-03-12 Novartis Ag Vacunas líquidas para múltiples serogrupos meningocócicos
GB0500787D0 (en) * 2005-01-14 2005-02-23 Chiron Srl Integration of meningococcal conjugate vaccination
KR101359953B1 (ko) * 2005-06-27 2014-02-21 글락소스미스클라인 바이오로지칼즈 에스.에이. 면역원성 조성물
AR064642A1 (es) 2006-12-22 2009-04-15 Wyeth Corp Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi
WO2008149238A2 (en) * 2007-06-04 2008-12-11 Novartis Ag Formulation of meningitis vaccines
EP2462949A3 (en) * 2007-10-19 2012-09-05 Novartis AG Meningococcal vaccine formulations
WO2009076158A1 (en) 2007-12-07 2009-06-18 Novartis Ag Compositions for inducing immune responses
DK2608805T4 (da) 2010-08-23 2025-06-30 Wyeth Llc STABILE FORMULERINGER AF NEISSERIA MENINGITIDIS rLP2086 ANTIGENER
RU2546873C2 (ru) 2010-09-10 2015-04-10 УАЙТ ЭлЭлСи Нелипидизированные варианты антигенов neisseria meningitidis orf2086
SA115360586B1 (ar) 2012-03-09 2017-04-12 فايزر انك تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
PE20190458A1 (es) 2012-03-09 2019-04-01 Pfizer Composiciones de neisseria meningitidis y metodos de las mismas
WO2014136064A2 (en) 2013-03-08 2014-09-12 Pfizer Inc. Immunogenic fusion polypeptides
CA2923129C (en) 2013-09-08 2020-06-09 Pfizer Inc. Neisseria meningitidis compositions and methods thereof
MX391027B (es) 2015-02-19 2025-03-21 Pfizer Composiciones de neisseria meningitidis y metodos de la misma.
PE20191107A1 (es) 2017-01-31 2019-08-26 Pfizer Composiciones de neisseria meningitidis y metodos respectivos
CN115605222A (zh) 2019-09-27 2023-01-13 辉瑞公司（Us） 脑膜炎奈瑟氏菌组合物及其方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4902506A (en) * 1983-07-05 1990-02-20 The University Of Rochester Immunogenic conjugates
US4451446A (en) 1982-03-04 1984-05-29 Smithkline-Rit Process for the preparation of polysaccharide-protein complexes from bacterial capsules, obtained products and immunogenic compositions containing them
US4619828A (en) * 1982-07-06 1986-10-28 Connaught Laboratories, Inc. Polysaccharide exotoxoid conjugate vaccines
US4459286A (en) * 1983-01-31 1984-07-10 Merck & Co., Inc. Coupled H. influenzae type B vaccine
IT1187753B (it) * 1985-07-05 1987-12-23 Sclavo Spa Coniugati glicoproteici ad attivita' immunogenica trivalente
US5371197A (en) * 1991-09-24 1994-12-06 Merck & Co., Inc. Protein-dimeric polysaccharide conjugate vaccine
GB9202219D0 (en) * 1992-02-03 1992-03-18 Connaught Lab A synthetic heamophilus influenzae conjugate vaccine
IT1262896B (it) * 1992-03-06 1996-07-22 Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini.
GB9422096D0 (en) * 1994-11-02 1994-12-21 Biocine Spa Combined meningitis vaccine
US5628496A (en) 1995-06-07 1997-05-13 Avm, Inc. Pneumatic spring
US6048527A (en) * 1996-08-27 2000-04-11 Chiron Corporation Antibodies that define unique Meningococcal B epitopes and vaccine compositions

Also Published As

Publication number Publication date
EP1312377A2 (en) 2003-05-21
EP2204185A1 (en) 2010-07-07
WO1996014086A1 (en) 1996-05-17
EP2204185A8 (en) 2010-10-27
DE69531501T2 (de) 2004-06-24
EP0789587B1 (en) 2003-08-13
JP4871770B2 (ja) 2012-02-08
DE69531501T3 (de) 2008-11-13
DK0789587T3 (da) 2003-12-01
ES2204967T5 (es) 2008-07-01
US6251401B1 (en) 2001-06-26
CA2204277A1 (en) 1996-05-17
EP0789587A1 (en) 1997-08-20
CA2204277C (en) 2010-02-02
JPH10509701A (ja) 1998-09-22
JP3989951B2 (ja) 2007-10-10
DK0789587T4 (da) 2008-08-04
CA2689871A1 (en) 1996-05-17
GB9422096D0 (en) 1994-12-21
CY2423B1 (en) 2004-11-12
ES2204967T3 (es) 2004-05-01
PT789587E (pt) 2003-12-31
JP2007169302A (ja) 2007-07-05
DE69531501D1 (de) 2003-09-18
EP1312377A3 (en) 2004-02-04
JP2011016850A (ja) 2011-01-27
EP0789587B2 (en) 2008-04-02

Similar Documents

Publication Publication Date Title
ATE246936T1 (de) Kombiniertes menningitis vakzine
DE69630181D1 (de) Anästhesiegerät
FR2717423B1 (fr) Instrument d'écriture.
FR2735031B1 (fr) Appareil d'anesthesie loco-regionale.
FI932264A7 (fi) Paperikoneen kitaformeri
DE69612278D1 (de) Ritzvorrichtung
DE69504878D1 (de) Pneumatische Vorrichtung
FR2736937B1 (fr) Machine d'etirage-texturation par fausse torsion
KR970002725A (ko) 현금 자동 거래 장치
FR2705239B1 (fr) Aiguille clivable.
FR2716759B1 (fr) Etage de formatage d'opérandes optimisé.
KR960020265U (ko) 무균작업대
ITTO910901A1 (it) Procedimento per l'incollaggio di pezzi di lamiera.
Beaglehole et al. Teacher's guide for basic epidemiology
ES1032049Y (es) Dispositivo individual neumatico antitraumatismos.
ES1028831U (es) Poste indicador de parada para cuatro lineas de transporte: compacto, removible, apilable y con soporte publicitario.
KR950000659U (ko) 공압식 소형펀칭기
FR2730784B1 (fr) Amplificateur pneumatique
UA912S (uk) Верстат деревообробний комбінований універсальний
ITSV950018A0 (it) Utensile chirurgico per interventi in laparoscopia.
ES1031730Y (es) Maquina flejadora perfeccionada.
KR940026479U (ko) 화초재배가 되도록 한 상자형 엽서
KR970006014A (ko) 후륜 2축 대형차량의 에이. 비. 에스/에이. 에스. 알 장치
KR960033802U (ko) 서류용 지철구
IT1280971B1 (it) Macchina aspatrice perfezionata.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0789587

Country of ref document: EP

UEP Publication of translation of european patent specification

Ref document number: 0789587

Country of ref document: EP